At Virion Therapeutics, We Believe a Future Free of Cancer and Chronic Infectious Diseases Is Within Reach
Driven by science, our mission is to revolutionize the immunotherapy treatment landscape, focusing on the development of novel, adaptable, and accessible CD8+ T cell-based technologies.
Our transformative platform is first in its class, offering a unique methodology that combines innovative and established approaches to elicit a superior CD8+ T cell response. Novel genetically encoded checkpoint modifiers are delivered alongside optimized target-specific antigens via an immunogenic and adaptable viral vector platform that promotes potent, prolonged, and broad CD8+ T cell responses.
With potential applications across a range of cancers and chronic infectious diseases, our proprietary technology provides us with a robust pipeline. Our lead product, VRON-0200, is under investigation as a potential functional cure for the treatment of chronic hepatitis B virus (HBV) – a first-in-human clinical study is planned to initiate in late 2022.
Founded in 2018 to advance technology licensed from The Wistar Institute, we have assembled a world-class management team and an industry-leading global Board of Directors, with proven experience in the biotechnology sector, as well as extensive preclinical and clinical expertise in antiviral, vaccine, oncology, and immuno-oncology.
Company Details
- Employees
- 8
- Founded
- -
- Address
- 7 Creek Bend Court, Newark,de 19711,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.viriontx.com/
- Keywords
- Infectious diseases, Cancer, Immunotherapy.
- HQ
- Newark, DE
Virion Therapeutics, Llc Questions
Virion Therapeutics, Llc's website is https://www.viriontx.com/
Virion Therapeutics, Llc's LinkedIn profile is https://www.linkedin.com/company/virion-therapeutics
Virion Therapeutics, Llc has
8 employees.
View email and phone details for 8
employees at Virion Therapeutics, Llc.
Virion Therapeutics, Llc's industry is
Biotechnology Research
Virion Therapeutics, Llc's top competitors are
Nektar Therapeutics,
Eilean Therapeutics,
Nrx Pharmaceuticals, Inc.,
Gaba Therapeutics, Inc,
Zepteon, Inc.,
Virion Biotherapeutics,
Avobis Bio,
Speratum Biopharma, Inc.,
Ocean Biomedical,
Cardax, Inc..
Virion Therapeutics, Llc's categories are Biotechnology Research
Virion Therapeutics, Llc's founding year is 2018
